Study Compares Long-Term Benefits of Bariatric Surgery and GLP-1 Drugs for Obesity and Diabetes

A retrospective study in JAMA Network Open suggests that bariatric metabolic surgery may offer greater long-term clinical and economic advantages for eligible patients with obesity and diabetes compared to GLP-1 receptor agonist therapy. The research indicated lower ongoing costs for surgery patients due to reduced medication and hospitalization expenses, alongside more substantial improvements in BMI and HbA1c.